Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatment of serious diseases with significant unmet medical needs in the orphan drug segment.

Upcoming event

Latest presentation

Latest Report

Calendar and upcoming reports

August 22, 2024

Interim Report Q2 2024 (7:00am CEST)

November 8, 2024

Interim Report Q3 2024 (7:00am CET)

Joshua’s Story



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10